Search

everythinglearnresearchcommunity

for

Search:↓

Women with PCOS often have metabolic issues like insulin resistance and a higher risk of diabetes and abnormal lipid levels.

Women with PCOS often have insulin resistance, abnormal lipid levels, and a higher risk of diabetes and heart disease; lifestyle changes and medication like metformin can help manage these risks.

People with PCOS, especially if obese, often have NAFLD, linked to obesity, insulin resistance, and high androgen levels.

Balding men, especially young ones, may have higher risk of heart issues and diabetes; check cholesterol levels.

Metformin and rosiglitazone improve blood vessel function in women with PCOS, with metformin also reducing insulin resistance and testosterone levels.

Indian women with PCOS from Delhi and Srinagar show different symptoms, with Delhi women having higher obesity and blood sugar issues, and Srinagar women showing more hair growth and testosterone levels.

No clear link between hair loss and metabolic syndrome, but some differences in blood pressure and glucose levels.

Men with a certain type of hair loss (vertex type AGA) may have higher levels of bad fats (triglycerides) and lower levels of good cholesterol (HDL), suggesting they could be at risk for high fat levels in the blood (hyperlipidemia).

Polycystic Ovary Syndrome is linked to higher risk of hypertension and heart disease.

Obese women with PCOS show a male-like pattern in certain fat tissue gene expressions.

Women with early onset androgenetic alopecia have worse lipid profiles.

People with male pattern baldness are more likely to have metabolic syndrome.

The case emphasizes the need for careful screening in children for insulin resistance and related conditions.

Tofacitinib is safe and effective for severe alopecia areata, but hair loss may return 2 months after stopping treatment.

Testosterone therapy in transgender men has both desired effects like increased muscle mass and potential health risks such as higher cardiovascular risk.

Combining liraglutide and metformin helps obese women with PCOS who didn't lose weight on metformin alone to lose more weight.

Long-term testosterone therapy can cause hormone suppression, affect prostate and heart health, and alter physical characteristics, but does not increase prostate cancer risk and needs more research for full risk assessment.

Red ginseng may improve immunity, fatigue, memory, blood circulation, and menopausal symptoms, and is generally safe to consume.

Obese women with PCOS are more likely to have fatty liver disease.

Low-dose flutamide helps reduce excessive hair growth and is even more effective with birth control, without bad effects on blood fats.

Cross-sex hormone therapy is important for managing gender dysphoria and requires careful monitoring and healthcare provider education.

Mild essential fatty acid deficiency can cause health issues and is worsened by low-fat diets.

The document concludes that proper diagnosis and tailored long-term treatment can effectively manage androgenic disorders in women, improving patient care outcomes.

Lepidium sativum seed extracts helped reduce inflammation and improve insulin response in obese rats on a high-fat diet.

Removing myelin protein zero-like 3 in mice leads to better metabolism and resistance to obesity.

Testosterone therapy seems safe for short-term use in postmenopausal women with low sexual desire, but more research on long-term effects is needed.

The conclusion is that there's no significant link between male pattern baldness and the severity of coronary artery disease.

High levels of male hormones and irregular periods best predict how well PCOS patients will respond to metformin treatment.

Young women with PCOS and no other heart risk factors have normal heart function.

HSD3B1 gene variant and being overweight linked to hair loss in women with polycystic ovary syndrome.